Nearly two years since SARS-CoV-2 created a global pandemic, we know that some people may suffer from ongoing symptoms long after the effects of the initial phase of an acute infection.
In the first half of 2020, the terms “long COVID” or “Long Haulers” already gained popularity, with many people reporting that they were experiencing ongoing symptoms. Still, the exact mechanism of long COVID is not yet clear. There is no consistent definition nor accepted diagnostic criteria.
Even in normal times, disability assessment is an art as much as a science; assessors almost never have all the facts and must fill in missing information with scientific understanding and common sense. Yet in the case of these claims, scientific understanding is still forming as the COVID-19 virus evolves. That’s why claims experts from RGA’s global, South African and U.S. Group teams have developed a three-part long COVID Disability Claims Toolkit to help guide claims assessors in identifying potential long COVID claims, assessing disability claims, and preparing claimants, when possible, to return to work. See the end of this article for further details.
RGA’s Dr. Sheetal Salgonkar, Vice President and Medical Director, and Marilda Kotze, Vice President, Head of Global Claims, led a lively insurer roundtable discussion about ways to assess and address this complex constellation of conditions. RGA met with Sheetal and Marilda to revisit some of the more popular discussion topics and answer new questions:
We’re talking about a wide range of more than 200 symptoms that defy easy categorization, vary in severity and duration, and can impact multiple organs. Even routine physical exertion, like light housework, leaves these individuals feeling exhausted. Some ache all over. Others have trouble concentrating and stumble over simple calculations or cannot fulfill regular responsibilities at home or at work. The most common complaints include fatigue, headache, pain, myalgia, attention disorder, hair loss, dyspnea, ageusia, and anosmia. There is also Post COVID tachycardia syndrome, which usually affects young women.
Although there has been no agreement on one universal definition for some time, more guidance is emerging. On October 6, 2021, the World Health Organization (WHO) published a clinical case definition:
“Post COVID-19 condition occurs in individuals with a history of probable or confirmed SARS-CoV-2 infection, usually 3 months from the onset of COVID-19 with symptoms that last for at least 2 months and cannot be explained by an alternative diagnosis. Common symptoms include fatigue, shortness of breath, cognitive dysfunction but also others and generally have an impact on everyday functioning. Symptoms may be new onset following initial recovery from an acute COVID-19 episode or persist from the initial illness. Symptoms may also fluctuate or relapse over time.”
Prior to the WHO clinical case definition being published, the U.K. National Institute for Health Research identified four subtypes of long COVID and the U.K. National Institute for Health and Care Excellence distinguished long COVID suffers as those with symptoms that linger four to 12 weeks after infection, with Post COVID appearing after 12 weeks-time. On the other hand, the U.S. National Institutes of Health names a single condition: Post-Acute Sequelae of COVID or PASC.
The maximum duration of long COVID symptoms is currently unknown. Symptoms wax and wane in severity and differ among individuals.
There is no diagnostic test for long COVID – coronavirus antibodies wane naturally and may not be detectable in claimants with this condition. Of course, this can complicate tracking and testing. It doesn’t help that sufferers can present with an array of subjective complaints, such as fatigue, chronic pain, or brain fog, that are difficult to capture with traditional screens, blood tests or imaging.
Researchers have detected certain symptom patterns, though. Currently long COVID is more common in females and in people at younger ages. There is no evidence that the severity of a COVID-19 infection is an indicator of post viral symptoms; people who were asymptomatic or had mild COVID-19 symptoms can develop the condition. Still, admission to an intensive care unit is a very poor prognosticator for return to work, with only approximately 50% of people retuning to work one-year post ICU discharge.
RGA’s toolkit offers a symptom checker to help claims assessors identify combinations of symptoms that may point toward long COVID. Researchers are already identifying 12-week symptom profiles, including a cluster that share respiratory symptoms and another group that is more distinguished by deep fatigue.
Vice President, Global Head of Claims
RGA South Africa
Director, Claims Consultant
US Group Disability Reinsurance
Not necessarily. To qualify for disability, an individual must demonstrate an impairment that prevents substantial, gainful work. Determining functionality as it relates to occupational duties is the most important element of the adjudication process and a positive COVID-19 test is not a prerequisite to completing a full assessment.
First, master long COVID symptom patterns, second maximize claims management performance, and finally maintain a disciplined approach to return-to-work assessment and understand that these cases are complex and no one size fits all. In other words, personalized care is critical alongside multidisciplinary support to enable self-management. Early intervention is very important to achieve a positive outcome. Proactive and transparent communication are cornerstones for this approach to be successful.
While there is still much to discover about the long-term effects of COVID-19, all the current literature points towards a slow and gradual return to activity. This requires a clear understanding of the presenting symptoms or impairments to determine if the claimant has recovered sufficiently to start setting functional goals.
Tele-interviews and regular engagement with the claimant are essential. In many instances managing these cases will require significant time and input from a claims team. The claimant’s symptoms can fluctuate from day to day, so having a clear understanding of the claimant’s functional abilities and his or her motivation to return to work is key. Likewise, the identification of potential barriers that may impact progress is critical.
Unless the claimant is being treated by a multidisciplinary team, they are unlikely to have a clear return to work plan. This is an opportunity for insurers to add value by assisting with support and education. While physician questionnaires typically advise rest, evidence supports the fact that activity is beneficial. Claims assessors may have an important role to play in communicating with providers and professional occupational therapists proactively about that fact. We all share the same goal: recovery.
Lastly, we don’t need to do all the case management ourselves. We have time to find suitably qualified specialists in our markets who can assist claimants with their recovery and ultimately help them to return to work.
It is worth emphasizing that these claimants require active and ongoing treatment, preferably at specialist clinics – and not a “wait and see” approach. The best outcomes arise from the work of a multi-disciplinary, cross-trained team, personalized rehabilitation planning, and psychiatric referral when warranted. RGA’s toolkit includes assessment best practices and clinical evaluation tools. Currently, the industry has an opportunity, while claim numbers are still relatively low, to assemble the right people with the right specialized expertise and the right processes to manage these complex claims. The time to act is now.
To increase understanding of the ever-evolving condition that is known as “long COVID," RGA has launched a Long CIVID-19 Assessment Toolkit that can be accessed via the RGA Global Claims Manual/Guide.
The toolkit is intended to help clients manage these potentially complex claims and focuses on disability income claims management.
The toolkit is made up of 3 parts:
| Part 1 “Symptoms & Definitions” |
| One of the many challenges with long COVID is the wide range of symptoms that people may suffer from and varying criteria for diagnosis. Part 1 is designed to help assessors understand common (objective and subjective) symptoms and general considerations when diagnosing long COVID (including ICD-10 codes). |
| Part 2 “Initial Assessment Practices” |
| This section offers input on structuring teams and performing initial assessments as well as ongoing claims management. Objective / clinical tests that can help to establish baseline function and impairment are also included. |
| Part 3 “Return to Work” |
| One of disability claims managers' main goals is to help claimants return to work in a safe and sustainable manner. This final part of the toolkit provides a pathway to set realistic goals in supporting this goal. |
| While there is still much to discover about the long-term effects of COVID-19, it is apparent that for at least some individuals, recovery from the virus does not mean a return to their old lives. Claims assessors have a unique role to play in guiding the discussion and response to long COVID. |
